Domain Therapeutics raised €40M in a Series A round in May 2022. The company is based in Strasbourg,, France. Investors in the round: 3B Future Health Fund, adMare BioInnovations, CTI Life Sciences and 7 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
